Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics (IOVA)
:IOVA
IOVA Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IOVA Stock 12 Month Forecast
Average Price Target
$6.50
▲(182.61% Upside)
| Highest Price Target$9.00 | Average Price Target$6.50 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
―
Hold
―
Reiterated
12/05/25
Barclays
$9
Buy
291.30%
Upside
Reiterated
11/24/25
TD Cowen
$5
Buy
117.39%
Upside
Reiterated
11/10/25
Goldman Sachs
$1→$1.5
Sell
-34.78%
Downside
Reiterated
11/10/25
H.C. Wainwright
$20→$9
Buy
291.30%
Upside
Reiterated
11/06/25
Chardan Capital
$20
Buy
769.57%
Upside
Reiterated
08/08/25
Updating our model for 2Q25 financials and these updates shifts our PT to $20.
Wells Fargo
$18→$14
Buy
508.70%
Upside
Reiterated
08/08/25
Citizens JMP
―
Hold
―
Reiterated
07/15/25
UBS
$2
Hold
-13.04%
Downside
Downgraded
05/16/25
Robert W. Baird
$20→$3
Hold
30.43%
Upside
Downgraded
05/09/25
Jefferies
$23→$18
Buy
682.61%
Upside
Reiterated
03/13/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
―
Hold
―
Reiterated
12/05/25
Barclays
$9
Buy
291.30%
Upside
Reiterated
11/24/25
TD Cowen
$5
Buy
117.39%
Upside
Reiterated
11/10/25
Goldman Sachs
$1→$1.5
Sell
-34.78%
Downside
Reiterated
11/10/25
H.C. Wainwright
$20→$9
Buy
291.30%
Upside
Reiterated
11/06/25
Chardan Capital
$20
Buy
769.57%
Upside
Reiterated
08/08/25
Updating our model for 2Q25 financials and these updates shifts our PT to $20.
Wells Fargo
$18→$14
Buy
508.70%
Upside
Reiterated
08/08/25
Citizens JMP
―
Hold
―
Reiterated
07/15/25
UBS
$2
Hold
-13.04%
Downside
Downgraded
05/16/25
Robert W. Baird
$20→$3
Hold
30.43%
Upside
Downgraded
05/09/25
Jefferies
$23→$18
Buy
682.61%
Upside
Reiterated
03/13/25
Best Analysts Covering Iovance Biotherapeutics
1 Month
xxx
Success Rate
12/28 ratings generated profit
Average Return
-0.98%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of -0.98% per trade.
3 Months
xxx
Success Rate
10/12 ratings generated profit
Average Return
+4.76%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +4.76% per trade.
1 Year
Success Rate
7/12 ratings generated profit
Average Return
-19.55%
reiterated a buy rating last month
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of -19.55% per trade.
2 Years
xxx
Success Rate
7/12 ratings generated profit
Average Return
-18.45%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of -18.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IOVA Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
13
10
9
9
8
Buy
1
1
0
0
0
Hold
22
21
21
17
17
Sell
1
1
0
1
1
Strong Sell
0
0
0
0
0
total
37
33
30
27
26
Each month's total comprises the sum of three months' worth of ratings.
IOVA Financial Forecast
IOVA Stock Forecast FAQ
What is IOVA’s average 12-month price target, according to analysts?
Based on analyst ratings, Iovance Biotherapeutics’s 12-month average price target is 6.50.
What is IOVA’s upside potential, based on the analysts’ average price target?
Iovance Biotherapeutics has 182.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IOVA a Buy, Sell or Hold?
Iovance Biotherapeutics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Iovance Biotherapeutics’s price target?
The average price target for Iovance Biotherapeutics is 6.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $9.00 ,the lowest forecast is $4.00. The average price target represents 182.61% Increase from the current price of $2.3.
The highest analyst price target is $9.00 ,the lowest forecast is $4.00. The average price target represents 182.61% Increase from the current price of $2.3.
What do analysts say about Iovance Biotherapeutics?
Iovance Biotherapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of IOVA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.